Nady Roodi

4.0k total citations · 1 hit paper
20 papers, 3.2k citations indexed

About

Nady Roodi is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Nady Roodi has authored 20 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Nady Roodi's work include Estrogen and related hormone effects (15 papers), Glutathione Transferases and Polymorphisms (10 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Nady Roodi is often cited by papers focused on Estrogen and related hormone effects (15 papers), Glutathione Transferases and Polymorphisms (10 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Nady Roodi collaborates with scholars based in United States, Italy and Germany. Nady Roodi's co-authors include Fritz F. Parl, William D. Dupont, Lisa Bailey, Jason H. Moore, Marylyn D. Ritchie, Lance W. Hahn, Sheila Dawling, C S Verrier, Cindy J. Yee and F. Peter Guengerich and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Nady Roodi

20 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multifactor-Dimensionality Reduction Reveals High-Order Interactions among Estrogen-Metabolism Genes in Sporadic Breast Cancer

2001 1.4k citations Marylyn D. Ritchie, Lance W. Hahn et al. The American Journal of Human Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nady Roodi United States	18	1.8k	1.6k	509	468	367	20	3.2k
Joanna Amberger United States	12	3.0k 1.7×	1.4k 0.8×	181 0.4×	389 0.8×	481 1.3×	18	4.7k
Joseph Dinchuk United States	15	1.2k 0.7×	1.6k 1.0×	679 1.3×	655 1.4×	206 0.6×	20	4.7k
Anders Berkenstam Sweden	21	1.5k 0.8×	1.0k 0.6×	623 1.2×	520 1.1×	651 1.8×	32	2.8k
Linnea M. Baudhuin United States	23	861 0.5×	577 0.4×	323 0.6×	286 0.6×	244 0.7×	72	2.3k
Angela Risch Germany	37	2.6k 1.5×	579 0.4×	801 1.6×	1.3k 2.7×	306 0.8×	83	4.1k
Claes Wadelius Sweden	36	3.4k 1.9×	800 0.5×	348 0.7×	308 0.7×	829 2.3×	127	5.9k
Victoria M. Pratt United States	33	952 0.5×	870 0.5×	381 0.7×	288 0.6×	1.1k 3.1×	106	3.3k
Aliana Guerrieri‐Gonzaga Italy	30	970 0.5×	816 0.5×	1.2k 2.3×	858 1.8×	147 0.4×	106	2.6k
Neil Miller United States	28	984 0.5×	1.1k 0.6×	277 0.5×	213 0.5×	643 1.8×	60	2.9k
Ellen M. McDonagh United States	22	1.0k 0.6×	596 0.4×	460 0.9×	202 0.4×	837 2.3×	35	2.9k

Countries citing papers authored by Nady Roodi

Since Specialization

Citations

This map shows the geographic impact of Nady Roodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nady Roodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nady Roodi more than expected).

Fields of papers citing papers by Nady Roodi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nady Roodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nady Roodi. The network helps show where Nady Roodi may publish in the future.

Co-authorship network of co-authors of Nady Roodi

This figure shows the co-authorship network connecting the top 25 collaborators of Nady Roodi. A scholar is included among the top collaborators of Nady Roodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nady Roodi. Nady Roodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crooke, Philip S., Christina Justenhoven, Hiltrud Brauch, et al.. (2011). Estrogen Metabolism and Exposure in a Genotypic–Phenotypic Model for Breast Cancer Risk Prediction. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1502–1515. 21 indexed citations

Parl, Fritz F., Sheila Dawling, Nady Roodi, & Philip S. Crooke. (2009). Estrogen Metabolism and Breast Cancer. Annals of the New York Academy of Sciences. 1155(1). 68–75. 60 indexed citations

Bradley, C.A., Roelof van der Meer, Nady Roodi, et al.. (2007). Carcinogen-induced histone alteration in normal human mammary epithelial cells. Carcinogenesis. 28(10). 2184–2192. 38 indexed citations

Hachey, David L., et al.. (2007). Cytochrome P450 1B1–Mediated Estrogen Metabolism Results in Estrogen-Deoxyribonucleoside Adduct Formation. Cancer Research. 67(2). 812–817. 67 indexed citations

Crooke, Philip S., Marylyn D. Ritchie, David L. Hachey, et al.. (2006). Estrogens, Enzyme Variants, and Breast Cancer: A Risk Model. Cancer Epidemiology Biomarkers & Prevention. 15(9). 1620–1629. 31 indexed citations

Roodi, Nady, William D. Dupont, Jason H. Moore, & Fritz F. Parl. (2004). Association of Homozygous Wild-Type Glutathione S-Transferase M1 Genotype with Increased Breast Cancer Risk. Cancer Research. 64(4). 1233–1236. 54 indexed citations

Dawling, Sheila, David L. Hachey, Nady Roodi, & Fritz F. Parl. (2004). In Vitro Model of Mammary Estrogen Metabolism: Structural and Kinetic Differences between Catechol Estrogens 2- and 4-Hydroxyestradiol. Chemical Research in Toxicology. 17(9). 1258–1264. 39 indexed citations

Hachey, David L., Sheila Dawling, Nady Roodi, & Fritz F. Parl. (2003). Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism.. PubMed. 63(23). 8492–9. 50 indexed citations

Dawling, Sheila, Nady Roodi, & Fritz F. Parl. (2003). Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.. PubMed. 63(12). 3127–32. 62 indexed citations

10.

Dawling, Sheila, Nady Roodi, Ray Mernaugh, Xiahong Wang, & Fritz F. Parl. (2001). Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.. PubMed. 61(18). 6716–22. 223 indexed citations

11.

Ritchie, Marylyn D., Lance W. Hahn, Nady Roodi, et al.. (2001). Multifactor-Dimensionality Reduction Reveals High-Order Interactions among Estrogen-Metabolism Genes in Sporadic Breast Cancer. The American Journal of Human Genetics. 69(1). 138–147. 1441 indexed citations breakdown →

12.

Dawling, Sheila, et al.. (2000). Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.. PubMed. 60(13). 3440–4. 274 indexed citations

13.

Roodi, Nady, et al.. (1998). Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.. PubMed. 58(22). 5038–41. 187 indexed citations

14.

Bailey, Lisa, et al.. (1998). Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.. PubMed. 58(1). 65–70. 193 indexed citations

15.

Roodi, Nady, Cindy J. Yee, Lisa Bailey, et al.. (1997). High-Mobility Group (HMG) Protein HMG-1 and TATA-Binding Protein-Associated Factor TAF_II30 Affect Estrogen Receptor-Mediated Transcriptional Activation. Molecular Endocrinology. 11(8). 1009–1019. 64 indexed citations

16.

Roodi, Nady, Lisa Bailey, W Y Kao, et al.. (1995). Estrogen Receptor Gene Analysis in Estrogen Receptor-Positive and Receptor-Negative Primary Breast Cancer. JNCI Journal of the National Cancer Institute. 87(6). 446–451. 220 indexed citations

17.

Verrier, C S, Cindy J. Yee, Nady Roodi, et al.. (1995). The interaction of the estrogen receptor with its DNA response element is facilitated by the high mobility group protein, HMG-1. 78. 4 indexed citations

18.

Roodi, Nady, Lisa Bailey, C S Verrier, et al.. (1995). Analysis of the estrogen receptor (ER) gene, transcript and protein in ER-positive and -negative breast cancer cell lines. Endocrine Related Cancer. 2(4). 293–309. 1 indexed citations

19.

Yee, Cindy J., Nady Roodi, C S Verrier, & Fritz F. Parl. (1994). Microsatellite instability and loss of heterozygosity in breast cancer.. PubMed. 54(7). 1641–4. 165 indexed citations

20.

Patston, P A, Nady Roodi, Jürg A. Schifferli, et al.. (1990). Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.. Journal of Biological Chemistry. 265(18). 10786–10791. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact